219 related articles for article (PubMed ID: 14644827)
1. Oral contraceptives and reproductive system cancer.
Deligeoroglou E; Michailidis E; Creatsas G
Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
[TBL] [Abstract][Full Text] [Related]
2. [Combined oral contraception and the risk of reproductive organs cancer in women].
Medard M L; Ostrowska L
Ginekol Pol; 2007 Aug; 78(8):637-41. PubMed ID: 18050614
[TBL] [Abstract][Full Text] [Related]
3. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
5. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
Aust N Z J Public Health; 2015 Oct; 39(5):441-5. PubMed ID: 26437729
[TBL] [Abstract][Full Text] [Related]
6. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
7. The combined oral contraceptive. Risks and adverse effects in perspective.
Bagshaw S
Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
[TBL] [Abstract][Full Text] [Related]
8. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
9. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and cancer.
Holck S; Ebeling K
Arch Geschwulstforsch; 1986; 56(2):155-67. PubMed ID: 3518652
[TBL] [Abstract][Full Text] [Related]
11. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception and cancer of the female reproductive system.
Woods KL
J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
14. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
15. Health outcomes associated with use of hormonal contraception: breast cancer.
Schneyer R; Lerma K
Curr Opin Obstet Gynecol; 2018 Dec; 30(6):414-418. PubMed ID: 30239373
[TBL] [Abstract][Full Text] [Related]
16. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
Veljković M; Veljković S
Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and cancer. A review of the evidence.
La Vecchia C; Tavani A; Franceschi S; Parazzini F
Drug Saf; 1996 Apr; 14(4):260-72. PubMed ID: 8713694
[TBL] [Abstract][Full Text] [Related]
18. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
19. [Use of oral contraceptives and risk of cancer, a cohort study].
Kumle M; Alsaker E; Lund E
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
[TBL] [Abstract][Full Text] [Related]
20. The combined oral contraceptive pill in women over age forty.
Wong MT; Singh K
Ann Acad Med Singap; 2003 Sep; 32(5):624-31. PubMed ID: 14626790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
